Reprogramming the Course of Cancer and Diabetes

Family Office Marketplace > News > Reprogramming the Course of Cancer and Diabetes

Genprex, Inc is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options.

What they will learn from this webinar
How Genprex is bridging critical gaps in modern medicine by providing new treatment options to patients with cancer and diabetes
The Company’s oncology program and its modern combinational treatment approach to fight cancer
How its diabetes program could eliminate the need for insulin in diabetic patients

At Genprex, they believe their therapies offer a strong value proposition to the market to address unmet medical needs and save lives.

Generated by Feedzy